Bicycle Therapeutics (United Kingdom)
Bicycle Therapeutics is a Cambridge, United Kingdom-based company developing precision-guided therapeutics, primarily for solid tumor cancers.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Bicycle Therapeutics is a company based in Cambridge, United Kingdom. It describes itself as developing precision-guided therapeutics designed to penetrate deep into tissues and target intractable cancers, with all Bicycle® molecule candidates in development primarily targeting solid tumor cancers. The company states its aim is to become one of the world's leading solid tumor medicines companies, and it also works on therapeutic applications beyond oncology through collaborations with pharma partners and academic thought leaders.
History
Bicycle Therapeutics is a company based in Cambridge, United Kingdom. It develops precision-guided therapeutics intended to penetrate deep into tissues and target intractable cancers. All Bicycle® molecule candidates in development exploit the company's technology and have been developed primarily to target solid tumor cancers. The company also works on other therapeutic applications beyond oncology, including anti-infective, cardiovascular, ophthalmology, dementia, central nervous system, neuromuscular and respiratory areas, through collaborations with pharma partners and academic thought leaders.
Products and positioning
Precision-guided therapeutics for solid tumor cancers and other therapeutic areas.
Recent events
Bicycle Therapeutics prices $175 million public offering[4]
Reported:
Bicycle Therapeutics announced the pricing of an underwritten public offering of 3,240,741 American Depositary Shares at $54.00 per share, for gross proceeds of $175.0 million. The offering was expected to close on or about October 15, 2021, subject to customary conditions.
Bicycle Therapeutics appoints Jose-Carlos Gutierrez-Ramos to its board[5]
Reported:
Bicycle Therapeutics announced the appointment of Jose-Carlos (“JC”) Gutierrez-Ramos, Ph.D., to its Board of Directors.
Sources5 sources
- 1Bicycle Therapeuticsbicycletherapeutics.com
- 2Bicycle Therapeutics - Leadership - Bicycle Therapeuticsbicycletherapeutics.com
- 3Bicycle Therapeutics (United Kingdom)wikidata.org
- 4Bicycle Therapeutics为1.75亿美元公开发行定价finanznachrichten.de
- 5Bicycle Therapeutics任命Jose-Carlos Gutierrez-Ramos加入董事会finanznachrichten.de
Cite this profile: Cite the canonical profile. /brand-wiki/bicycle-therapeutics-united-kingdom · Editorial policy · How profiles are compiled